Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 15, 2009
A novel component of the metabolic syndrome: the oxidative stress
E Hopps, D Noto, G Caimi, et al.
Minerva Cardioangiologica
|
July 31, 2004
Genetic risk factors in myocardial infarction at young age
E Incalcaterra, E Hoffmann, M R Averna, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
August 30, 1981
[Preliminary observations on the comparative physiopathology of plasma lipoproteins: dog and human. I]
M R Averna, M C Fiore, G Montalto, et al.
The Journal of Biological Chemistry
|
July 13, 2000
A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides
Z Chen, R L Fitzgerald, M R Averna, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
November 1, 1994
Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2)
W A Groenewegen, E S Krul, M R Averna, et al.
Journal of Lipid Research
|
June 1, 1994
Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL
W A Groenewegen, M R Averna, J Pulai, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
August 30, 1981
[Serum lipoprotein fractions in chronic liver diseases with and without alcoholism]
G B Rini, M R Averna, G Montalto, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
July 30, 1982
Apo-lipoproteic pattern in type I complicated diabetes (I.D.D.) with microangiopathy and with no clinico-instrumental signs of macroangiopathy.--Note II
G B Rini, M R Averna, G Di Fede, et al.
Gerontology
|
January 1, 1995
Plasma lipid, apolipoprotein and Lp(a) levels in elderly normolipidemic women: relationships with coronary heart disease and longevity
C M Barbagallo, M R Averna, G Fradà, et al.
Mediators of Inflammation
|
August 13, 2014
Study of the correlations among some parameters of the oxidative status, gelatinases, and their inhibitors in a group of subjects with metabolic syndrome
E Hopps, R Lo Presti, M Montana, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 15, 2009
A novel component of the metabolic syndrome: the oxidative stress
E Hopps, D Noto, G Caimi, et al.
Minerva Cardioangiologica
|
July 31, 2004
Genetic risk factors in myocardial infarction at young age
E Incalcaterra, E Hoffmann, M R Averna, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
August 30, 1981
[Preliminary observations on the comparative physiopathology of plasma lipoproteins: dog and human. I]
M R Averna, M C Fiore, G Montalto, et al.
The Journal of Biological Chemistry
|
July 13, 2000
A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides
Z Chen, R L Fitzgerald, M R Averna, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
November 1, 1994
Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2)
W A Groenewegen, E S Krul, M R Averna, et al.
Journal of Lipid Research
|
June 1, 1994
Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL
W A Groenewegen, M R Averna, J Pulai, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
August 30, 1981
[Serum lipoprotein fractions in chronic liver diseases with and without alcoholism]
G B Rini, M R Averna, G Montalto, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
July 30, 1982
Apo-lipoproteic pattern in type I complicated diabetes (I.D.D.) with microangiopathy and with no clinico-instrumental signs of macroangiopathy.--Note II
G B Rini, M R Averna, G Di Fede, et al.
Gerontology
|
January 1, 1995
Plasma lipid, apolipoprotein and Lp(a) levels in elderly normolipidemic women: relationships with coronary heart disease and longevity
C M Barbagallo, M R Averna, G Fradà, et al.
Mediators of Inflammation
|
August 13, 2014
Study of the correlations among some parameters of the oxidative status, gelatinases, and their inhibitors in a group of subjects with metabolic syndrome
E Hopps, R Lo Presti, M Montana, et al.
Page
of 6